|
|
||||||||
Departments of 1 General Medicine and 3 Cardiology, Christchurch Hospital; 2 Department of Medicine, Christchurch School of Medicine, Christchurch, New Zealand; and 4 Howard Florey Institute, Melbourne, Australia
| |
ABSTRACT |
|---|
|
|
|---|
Cardiac sympathetic nerve activity (CSNA) is of major
importance in the etiology of heart disease but is impossible to
measure directly in humans. Ovine and human cardiovascular systems are similar; therefore, we have developed a method for the daily recording of CSNA in conscious sheep. After thoracotomy, electrodes were glued
into the left thoracic cardiac nerve and CSNA, blood pressure (BP), and
heart rate were recorded daily. Satisfactory recordings
7 days of
CSNA were obtained in 11 of 28 sheep (40%), mean recording time 10.6 days, range 7-47. During the first week, CSNA decreased gradually from
78 ± 8 at baseline to 60 ± 7 bursts/min on day 5 (P = 0.02) or from 76 ± 9 to 57 ± 7 bursts/100 beats on day 7 (P = 0.04).
Similarly, BP decreased from 103 ± 4 to 94 ± 4 mmHg (P = 0.03). Low-frequency heart rate variability
decreased from 0.12 ± 0.02 to 0.06 ± 0.02 ms2
on day 6 (P = 0.004) but was not correlated
to CSNA. In conclusion, CSNA that can be continually recorded in
conscious sheep decreases during the first week postsurgery and,
thereafter, stabilizes. This model should provide valuable insights in
future investigations of cardiac disease.
sympathetic nervous system; ovine model; baroreflex
| |
INTRODUCTION |
|---|
|
|
|---|
CARDIAC SYMPATHETIC NERVE activity (CSNA) is of major importance in cardiovascular disease but has not been measured directly in the conscious human. Increased cardiac sympathetic activity is thought to be involved in the etiology of left ventricular hypertrophy, failure, and arrhythmia (4). Direct recordings of CSNA are not possible without thoracotomy, and so human studies have used muscle sympathetic nerve activity (MSNA) or indirect measurements of CSNA (10, 13, 14, 16, 33). Furthermore, MSNA is increased in cardiovascular disease, but recordings are difficult to maintain, and CSNA is likely to be more sensitive for cardiac disease (25). To date, no long-term recordings of CSNA have been achieved in conscious animals. Ninomiya et al. (28) recorded CSNA in conscious cats for up to 6 days but day-to-day levels were not reported. Because it is difficult to maintain nerve recordings, previous investigators have concentrated on baroreflex slopes rather than daily recordings in the resting state. Furthermore, renal sympathetic nerve activity (RSNA) has been recorded in conscious animals and MSNA in humans, because the nerves are more accessible (8). CSNA has only been recorded short-term, during general anesthesia or immediately after thoracotomy (11, 27, 28). There are a number of concerns with these methods. First, baroreflex-modulated sympathetic activity represents only one part of the control of CSNA, which is also affected by higher functions, respiratory pathways, and chemoreceptors (12). Second, anesthesia decreases RSNA and CSNA (8, 27); and third, control of CSNA may be different to that of RSNA and MSNA (17).
We have attempted to overcome these problems by implanting long-term microneurographic recording electrodes in the cardiac sympathetic nerves to measure efferent, postganglionic CSNA continually in conscious sheep. This technique requires cardiac nerves of sufficient size to be easily identified and dissected at operation. The sheep heart is similar to that of the human in many ways, including dimensions of the chambers, coronary anatomy, and magnitude of hemodynamic variables such as blood pressure (BP), heart rate (HR), and cardiac output (22). Sympathetic innervation of the heart is bilateral and from the upper thoracic roots is similar to that of the human (24). Our laboratory has undertaken extensive cardiac neuroendocrine studies in sheep because of these advantages (3).
We wanted to know 1) whether it is possible to record CSNA in conscious animals each day; 2) the median duration of the recordings; 3) the proportion of thoracotomized animals in which recordings are possible for 1 wk or longer; 4) how CSNA changes after thoracotomy and if so, whether this is modulated by baroreflex activity; and 5) whether low frequency HR variability (LFHRV) correlates with CSNA.
| |
METHODS |
|---|
|
|
|---|
All procedures were undertaken in accordance with local animal ethics committee approval.
Electrode manufacture. A stainless steel insect pin (0.1 mm diameter × 10 mm length) was etched in acid to a fine point at both ends. One end was embedded in a 25-strand stainless steel wire-connecting lead and glued with cyanoacrylate leaving only a 1.5-mm recording tip protruding. The connecting lead measured 40 cm in length and was Teflon coated (Ben Clark; North Liberty, IA).
Thoracotomy and electrode placement.
Twenty-eight adult Coopworth sheep were starved for 48 h and water
restricted for 24 h before surgery. The well-established method of
recording RSNA in sheep (23) was modified for the purposes
of recording from the thoracic cardiac nerve. Surgical preparation was
conducted with the animal under standard thiopentone (17 mg/kg),
halothane, and nitrous oxide-oxygen anesthesia. With the animal in the
left lateral position, the left forelimb was manipulated to provide
access to the body of the fifth rib inferior to the scapula. A left
thoracotomy incision (~20 cm across) exposed the muscles deltoideus,
trapezius, and omotransversarius, which were split and retracted to
provide access to the rib. The periosteum was incised and the rib
removed. The thorax was clamped open, the parietal pleura was opened,
and the lung was retracted using wet packs. The thoracic cardiac
nerve(s) was then identified running obliquely across longus colli and
the esophagus to form an arcade on the superior margin of the azygus
vein, receiving branches from adjacent thoracic ganglia before reaching
the base of the heart where it formed the cardiac ganglion
(Fig. 1) (24). After the nerve was dissected clear of fat and tissue, the exposed tips of
the electrodes were pushed obliquely through the nerve sheath, ensuring
they were positioned in the center of the nerve. Up to five electrodes
were implanted and glued in place with cyanoacrylate glue
(Selley's superglue) and the connecting leads were
exteriorized through the thoracotomy wound. A Camino
arterial catheter (Medtronic AVE) was placed in the left common
carotid for continuous BP monitoring (model 110-4 Camino; San
Diego, CA), and a central venous line was positioned in the internal
jugular vein. Subcutaneous electrodes were applied to each limb quarter
for electrocardiogram (ECG) recordings. The intercostal space and split
muscle were repaired using synthetic nonabsorbable suture. A drain tube
was placed in the thorax to reestablish negative intrathoracic pressure
postoperatively. The skin was closed with silk sutures and connecting
leads were anchored to the wound sutures. Leads were also secured to
the sheep with elastic netting or string ties attached to the wool. The
drain was generally removed 24 h postoperatively and intramuscular pethidine (50 mg) was administered for postoperative analgesia.
|
CSNA recordings. Sympathetic recordings were made from the electrodes via a preamplifier with an active probe (model DAM-80; World Precision Instruments). The raw signal was processed by a nerve traffic analyzer and stored continuously with on-line BP and ECG in a dedicated personal computer using locally written software. The raw signal was filtered between 300 and 3,000 Hz and integrated using a time constant of 100 ms. Postganglionic efferent sympathetic nerve activity was identified by the following characteristics: 1) bursts were synchronized to the arterial pulse; 2) bursts decreased during a hexamethonium infusion (2 mg/kg over 2 h, performed in two animals only); 3) there was an inverse relationship between burst area and diastolic BP, most obvious during baroreflex tests performed on all animals (see below) (37). Only recordings with a signal-to-noise ratio of >2 were analyzed. CSNA was quantified by: 1) counting the number of bursts per minute (burst frequency); 2) counting the number of bursts per 100 heartbeats (burst incidence); and 3) measuring the area under the integrated signal per minute (burst area).
Baseline recordings. All recordings were undertaken by the same technician in a dedicated room between 9:00 and 11:00 AM each day while the animals were standing in cages. After the recordings, the animals were disconnected for the remaining 22 h of the day. Care was taken to ensure the animals were not disturbed, and recordings were only used if the variables were stable over the preceding 10 min. Simultaneous BP, HR, and CSNA levels were averaged each minute during a 5-min recording interval every day.
Baroreflex control of CSNA and HR.
After baseline measurements of BP, HR, and CSNA, BP was raised with an
intravenous bolus of phenylephrine (150 µg) to achieve a maximum
increase in diastolic BP of 10 mmHg over 1 min. One minute later,
intravenous nitroprusside was given (150 µg), to induce a 20 mmHg
ramp decrease in diastolic BP over the second minute (Fig.
2). The area under the integrated nerve
signal and the duration of the R-R intervals were expressed as
percentages of baseline levels and averaged every 5 s for 120 s. These values were logged and plotted against percent change in
diastolic and systolic BP to calculate baroreflex control of CSNA and
HR on days 3 and 6 after thoracotomy,
respectively.
|
HR variability.
All sinus beats from the 5-min interval were analyzed from the ECG
signal recorded at the same time as CSNA was measured. Frequency domain
analysis of HR variability was undertaken using the fast Fourier
transform method. The current guidelines for HRV are empirically
derived, mainly from human studies and no frequency domain analysis has
been undertaken on sheep (2, 38). We measured spectral
power in two frequency domains: LFHRV 0.06-0.1 Hz and
high-frequency HRV (HFHRV, 0.15-0.4 Hz). We used absolute LFHRV
power (ms2) and normalized LFHRV power (normalized units,
nu) to assess sympathetic and parasympathetic effects on the sinus node
(17, 21). HFHRV is thought to represent mainly
parasympathetic cardiac activity but it is subject to respiratory rate
and tidal volume, both of which are variable in sheep after thoracotomy
(38). In one animal, we measured the effects of
-blockade on LFHRV and atropine on HFHRV as a means of validating
the frequency domains used.
Statistics. Within-group comparisons were made using ANOVA for repeated measures and where time effects were indicated, Fisher's least-significant difference test was used to compare specific time points with baseline. Individual correlations between variables were made using Pearson's correlation coefficient. Group correlations between CSNA and LFHRV were made using a general linear model, which allows for differences between animals.
| |
RESULTS |
|---|
|
|
|---|
Continuous recordings of CSNA were possible for over a week in 11 of 28 sheep. Nine recordings lasted between 7 and 14 days. Two
recordings lasted over 30 days and an example is shown (Fig. 3). Mean length of recording was 10.6 days (range 7-47). In the remaining 17 animals, there were five
perioperative deaths and 12 unsatisfactory recordings. Unsatisfactory
recordings included 10 sheep with absent recording fields from
day 1, and two sheep with recordings lasting <7 days. CSNA
burst area decreased during hexamethonium infusion in both sheep
tested, and an example is shown in Fig.
4. MBP and CSNA burst area decreased from
92 to 65 mmHg and from 35 to 6 U/min. HR increased from 110 to 135 beats/min. LFHRV increased from 0.16 ms2 at baseline to
0.2, 10 min after atropine 0.4 mg iv and decreased from 0.16 ms2 to 0.12, 20 min after atenolol (1 mg iv).
|
|
Changes in MBP, HR, CSNA (bursts/min and burst area/min) are shown for
the 11 sheep during the first 7 days after thoracotomy (Fig.
5). CSNA burst frequency
(P = 0.001) and incidence (P = 0.01)
changed with time, whereas burst area (P = 0.3) was not significantly changed. MBP changed with time (P = 0.02), whereas HR was stable (P = 0.1). CSNA burst
frequency gradually decreased from baseline at 78 ± 8 bursts/min
to be lower by day 5 (60 ± 7 bursts/min,
P = 0.02) and remained low on days 6 and
7 (57 ± 7 bursts/min, P = 0.008 and
54 ± 6 bursts/min, P = 0.003). CSNA burst area
tended to decrease from 52 ± 7 U/min at baseline to 40 ± 6 U/min on day 3 (P = 0.2) and remained at a
similar level, thereafter (38 ± 12 U/min on day 7,
P = 0.29). CSNA burst incidence decreased from baseline
at 76 ± 9 to 57 ± 7 bursts/100 beats on day 7 (P = 0.04). MBP decreased gradually during the first 7 days from 102 ± 4 mmHg at baseline to be lower by day
7 (94 ± 4 mmHg, P = 0.03), whereas HR
tended to decrease from 105 ± 6 to 97 ± 4 beats/min
(P = 0.11). Absolute LFHRV power decreased with time (P = 0.02), whereas normalized LFHRV remained stable
(P = 0.43). Absolute LFHRV power decreased from 0.12 ms2 at baseline to be lower on day 6 (0.06 ± 0.02 ms2, P = 0.004) and remained at
0.06 ± 0.02 ms2 on day 7 (P = 0.009) (Fig. 6).
Normalized LFHRV tended to decrease gradually from 0.19 nu at baseline
to 0.14 nu on day 7 (P = 0.15). No overall
correlation was found between daily measures of LFHRV and CSNA
bursts/min (R2 = 0.02, P = 0.5) or any other CSNA parameters. Analysis of limited data from five
animals recorded beyond 7 days did not show progressive decrease in
CSNA, MBP, HR, or LFHRV during the second week (Fig. 3). Baroreflex
control of CSNA varied between
2.0 ± 0.4 and
1.6 ± 0.2 normalized burst area/mmHg for days 3 and
6, respectively (P = 0.3). Baroreflex
control of HR remained between 2.0 ± 0.3 and 1.6 ± 0.2 normalized ms/mmHg for days 3 and 6, respectively (P = 0.2) (Fig. 6).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Satisfactory recordings of CSNA were achieved each day for a mean duration of 10.6 days after implantation of electrodes in 40% of sheep studied. We believe this to be the longest duration of CSNA recordings undertaken in conscious animals to date. CSNA and LFHRV decreased during the first week after thoracotomy and appeared to stabilize during the second week and subsequent weeks, although there was no significant correlation between CSNA and LFHRV. BP and HR followed a similar pattern, consistent with this observation. Baroreflex control of CSNA and HR remained constant implying that the decrease in CSNA was modulated by other mechanisms.
Advantages of conscious CSNA recordings. The recording of CSNA in conscious animal models promises to be the most direct and sensitive method for assessing changes in cardiac sympathetic control (12, 25). CSNA is easily quantifiable by measuring burst frequency, incidence, and area from the integrated waveform, but the field must be verified daily using standard criteria for sympathetic microneurography (37). We were also able to construct baroreflex slopes for CSNA and BP similar to those reported in RSNA studies (6-8, 15, 40). By measuring CSNA at the same time each day under stable conditions, we were able to demonstrate changes that occurred independently of baroreflex activity. Consistent daily recording times are important, because both absolute sympathetic activity and baroreflex slopes may be subject to circadian variation (26, 36). Reproducible resting recordings give additional information that may be more relevant to the conscious human than baroreflex ramp tests under general anesthesia or immediately after surgery. However, the finding that CSNA baroreflex activity remained constant for at least 7 days after surgery is reassuring for the interpretation of the RSNA studies. We hypothesize that CSNA is increased by the stress of thoracotomy and takes at least 5 days to return to its steady-state level. Therefore, measurements taken during the first week in postoperative animal models may be difficult to interpret (11, 27).
Most of the recent data on sympathetic activity and cardiac function comes from RSNA and CSNA recordings in anesthetized animals (7, 11, 20, 39, 40). Unfortunately, it has been clearly demonstrated that general anesthesia decreases RSNA in the rabbit and CSNA in the cat (8, 27). Therefore, measurement of CSNA in conscious animals may be more applicable to clinical studies of heart failure in humans (5, 14). In addition, CSNA should be measured rather than RSNA or MSNA because CSNA increases before RSNA in heart failure, and there is differentiation of sympathetic activity between vascular beds (18, 29, 33).HRV and CSNA. The simultaneous measurement of LFHRV and CSNA in the conscious animal is a novel approach to the assessment of HR variability as a noninvasive index of cardiac sympathetic activity (9). Because the HR of the sheep is similar to that of the human, the LF peak of spectral power (0.06-0.1 Hz) is also likely to be similar and was, therefore, chosen for this experiment. LF power is thought to represent baroreflex feedback on the sinus node in response to sympathetic effects on the vasculature, and we observed appropriate changes during parasympathetic and sympathetic inhibition. We demonstrated that although LFHRV and CSNA decrease in parallel during the week after thoracotomy, there was no clear correlation between the two. This is consistent with the human studies, in which no correlations were observed in normal subjects between baseline values of MSNA and LFHRV (30, 31, 34). In addition, heart failure studies have shown decreased LFHRV when cardiac sympathetic activity is increased (9, 19, 35). Although LFHRV has been shown to correlate with MSNA during sympathetic stimulation, it is probably determined by both sympathetic and parasympathetic effects on the sinus node. We conclude that absolute indices of sympathetic activity, including MSNA and CSNA are not comparable to oscillatory indices such as LFHRV and should not be used interchangeably. We were only able to show a significant decrease in absolute power LFHRV, because HFHRV was extremely variable between animals, and this would have affected normalized LFHRV measurements. We suspect this is because parasympathetic control of HR is closely linked to respiratory rate and tidal volume, both of which were variably affected by thoracotomy.
Limitations of the study. Unfortunately, the manufacture and placement of the recording electrodes is technically demanding, and the recordings are difficult to maintain. In addition to our validation techniques, postganglionic CSNA should be confirmed by ganglion blockade in all animals but we were concerned that this would cause prolonged hypotension and distress, even with phenylephrine cover. We had to strike a balance between validation of CSNA and preservation of the recordings. We had no way of predicting which electrodes would produce the recordings of longest duration and in over 50% of animals used, no recordings were possible. This was probably because the electrodes tended to pull from the nerves as the animal recovered after surgery. On the basis of limited data from five animals during the second week, it appeared that CSNA did not decrease further with time. Regular validation of the nerve signal was required to ensure that any apparent decrease was not secondary to loss of the recording field. We recorded multifiber postganglionic activity from the nerves supplying only the left side of the heart. Although the same cardiothoracic nerve was used in most animals, up to five electrodes were placed, and in some animals, more than one nerve was used (24). Detailed studies on cardiac sympathetic nerves in dogs have shown that they receive input from a number of thoracic ganglia apart from those in the paravertebral sympathetic chain, and there is considerable overlap from ipsilateral and contralateral nerves within most portions of the heart (1, 32). As in the human, the sympathetic nerves on the left predominantly supply the left ventricle and those on the right contribute more to the sinus node. This may be a source of variability of CSNA measurement between animals and may also explain the lack of correlation between CSNA and LFHRV. We did not measure respiratory rate and so cannot confirm our suggestion that this may have caused major variation in HFHRV and normalized LFHRV. The fast Fourier method for HRV requires stationarity for calculating spectral power and at least 264 heartbeats. We were, therefore, unable to measure changes in spectral power during the nitroprusside BP ramps as a means of validating the LF and HF bands. For practical reasons, it was only possible to record during 2 h of each day. We attempted to decrease sampling variation by ensuring the animals were hemodynamically stable and the recordings were made between 9:00 and 11:00 AM. Human studies have demonstrated circadian variation of MSNA baroreflex slopes and MSNA variation during sleep (26, 36).
In summary, we have demonstrated it is possible to undertake daily CSNA recordings in conscious sheep and that CSNA decreases during the first week after thoracotomy. As expected, this change does not appear to be modulated by baroreflexes. After thoracotomy, LFHRV does not correlate with CSNA. Daily analysis of resting CSNA in the conscious animal may provide new insights in the investigation of cardiac disease.| |
ACKNOWLEDGEMENTS |
|---|
Allastair McGill, Medical Illustration Department, Christchurch Hospital, prepared the figures.
| |
FOOTNOTES |
|---|
This study was supported by the Canterbury Cardiology Research Trust and The Heart Foundation of New Zealand.
Address for reprint requests and other correspondence: D. L. Jardine, Dept. of General Medicine, PO Box 4710, Christchurch, New Zealand (E-mail: david.jardine{at}cdhb.govt.nz).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6 December 2000; accepted in final form 7 September 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Armour, JA.
Myocardial ischaemia and the cardiac nervous system.
Cardiovasc Res
41:
41-54,
1999
2.
Berntson, GG,
Bigger JT,
Eckberg DL,
Grossman P,
Kaufmann PG,
Malik M,
Nagaraja HN,
Porges SW,
Saul JP,
Stone PH,
and
Van der Molen M.
Heart rate variability: origins, methods, and interpretive caveats.
Psychophysiology
34:
623-648,
1997[Web of Science][Medline].
3.
Charles, CJ,
Elliot JM,
Nicholls MG,
Rademaker MT,
and
Richards AM.
Myocardial infarction with and without reperfusion in sheep: early cardiac and neurohormonal changes.
Clin Sci (Lond)
98:
703-711,
2000[Medline].
4.
Cohn, JN.
Sympathetic nervous system activity and the heart.
Am J Hypertension
2, SupplS:
353S-356S,
1989[Medline].
5.
Dibner-Dunlap, ME,
Smith ML,
Kinugawa T,
and
Thames MD.
Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.
J Am Coll Cardiol
27:
358-364,
1996[Abstract].
6.
DiBona, GF,
Jones S,
and
Brooks V.
Angiotensin II receptor blockade and arterial baroreflex regulation of renal nerve activity in heart failure.
Am J Physiol Regulatory Integrative Comp Physiol
269:
R1189-R1196,
1995
7.
DiBona, GF,
and
Sawin LL.
Reflex regulation of renal nerve activity in cardiac failure.
Am J Physiol Regulatory Integrative Comp Physiol
266:
R27-R39,
1994
8.
Dorward, PK,
Riedel W,
Burke SL,
Gipps M,
and
Korner PI.
The renal sympathetic baroreflex in the rabbit.
Circ Res
57:
618-633,
1985
9.
Eckberg, DL.
Sympathovagal balance. A critical appraisal.
Circulation
96:
3224-3232,
1997
10.
Eisenhofer, G,
Friberg P,
Rundqvist B,
Quyyumi AA,
Lambert G,
Kaye DM,
Kopin IJ,
Goldstein DS,
and
Esler MD.
Cardiac sympathetic nerve function in congestive heart failure.
Circulation
93:
1667-1676,
1996
11.
Felder, RB,
and
Thames MD.
Interaction between cardiac receptors and sinoaortic baroreceptors in the control of efferent cardiac sympathetic nerve activity during myocardial ischemia in dogs.
Circ Res
45:
728-736,
1979
12.
Floras, JS.
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.
J Am Coll Cardiol
22, SupplA:
72A-84A,
1993.
13.
Francis, GS,
Cohn JN,
Johnson G,
Rector TS,
Goldman S,
and
Simon A.
Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II.
Circulation
87:
V140-V148,
1993.
14.
Grassi, G,
Seravalle G,
Cattaneo BM,
Lanfranchi A,
Vailati S,
Giannattasio C,
Del Bo A,
Sala C,
Bolla GB,
Pozzi M,
and
Mancia G.
Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.
Circulation
92:
3206-3211,
1995
15.
Huang, BS,
Yuan B,
and
Leenan FHH
Blockade of brain "ouabain" prevents the impairment of baroreflexes in rats after myocardial infarction.
Circulation
96:
1654-1659,
1997
16.
Imamura, Y,
Ando H,
Mitsuoka W,
Egashira S,
Masaki H,
Ashihara T,
and
Fukuyama T.
Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause.
J Am Coll Cardiol
26:
1594-1599,
1995[Abstract].
17.
Jaffe, RS,
Fung DL,
and
Behrman KH.
Optimal frequency for extracting information on autonomic activity from the heart rate spectogram.
J Auton Nerv Syst
46:
37-46,
1993.
18.
Kenny, MJ,
Barman SM,
Gebber GL,
and
Zhong S.
Differential relationships among discharges of postganglionic sympathetic nerves.
Am J Physiol Regulatory Integrative Comp Physiol
260:
R1159-R1167,
1991
19.
Kingwell, BA,
Thompson JM,
Kaye DM,
McPherson GA,
Jennings GL,
and
Esler MD.
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle nerve activity during human sympathetic nervous activation and failure.
Circulation
90:
234-240,
1994
20.
Kollai, M,
and
Koizumi K.
Reciprocal and non-reciprocal action of the vagal and sympathetic nerves innervating the heart.
J Auton Nerv Syst
1:
33-52,
1979[Web of Science][Medline].
21.
Lipsitz, LA,
Mietus J,
Moody GB,
and
Goldberger AL.
Spectral characteristics of heart rate variability before and during postural tilt.
Circulation
81:
1803-1810,
1990
22.
Markovitz, LJ,
Savage EB,
Ratcliffe MB,
Bavaria JE,
Kreiner G,
Iozzo RV,
Hargrove WC,
Bogen DK,
and
Edmunds LH.
Large animal model of left ventricular aneurysm.
Ann Thorac Surg
48:
838-845,
1989[Abstract].
23.
May, CN,
and
McAllen RN.
Brain angiotensinergic pathways and renal nerve inhibition by central hypertonic saline in conscious sheep.
Am J Physiol Regulatory Integrative Comp Physiol
272:
R593-R600,
1997
24.
McKibben, JS,
and
Getty R.
A comparative study of the cardiac innervation in domestic animals: sheep.
Acta Anat (Basel)
74:
228-242,
1969[Web of Science][Medline].
25.
Middlekauff, HR.
Mechanisms and implications of autonomic nervous system dysfunction in heart failure.
Curr Opin Cardiol
12:
265-275,
1997[Web of Science][Medline].
26.
Nakazato, T,
Shikama T,
Toma S,
Nakajima Y,
and
Masuda Y.
Nocturnal variation in human sympathetic baroreflex sensitivity.
J Auton Nerv Syst
70:
32-37,
1998[Web of Science][Medline].
27.
Ninomiya, I,
Matsukawa K,
Honda T,
Nishiura N,
and
Shirai M.
Cardiac sympathetic nerve activity and heart rate during coronary occlusion in awake cats.
Am J Physiol Heart Circ Physiol
251:
H528-H537,
1986
28.
Ninomiya, I,
Matsukawa K,
and
Nishiura N.
Cardiac and renal nerve activity in awake cats.
J Clin Exp Hypertension
A10, SupplI:
20-31,
1988.
29.
Ninomiya, I,
Nisimaru N,
and
Irisawa H.
Sympathetic nerve activity to the spleen, kidney, and heart in response to baroreceptor input.
Am J Physiol
221:
1346-1351,
1971.
30.
Notarious, CF,
Butler GC,
Ando S,
Pollard MJ,
Senn BL,
and
Floras JS.
Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.
Clin Sci (Lond)
96:
557-565,
1999[Medline].
31.
Pagani, M,
Montano N,
Porta A,
Malliani A,
Abboud FM,
Birkett C,
and
Somers VK.
Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans.
Circulation
95:
1441-1448,
1997
32.
Randall, WC,
Armour JA,
Geis WP,
and
Lippincott DB.
Regional cardiac distribution the sympathetic nerves.
Fed Proc
31:
1199-1208,
1972[Web of Science][Medline].
33.
Rundqvist, B,
Elam M,
Bergmann-Sverrisdottir Y,
Eisenhofer G,
and
Friberg P.
Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
Circulation
95:
169-175,
1997
34.
Saul, JP,
Rea RF,
Eckberg DL,
Berger RD,
and
Cohen RJ.
Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity.
Am J Physiol Heart Circ Physiol
258:
H713-H721,
1990
35.
Saul, JP,
Yutaka A,
Berger RD,
Lilly LS,
Colucci WS,
and
Cohen RJ.
Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis.
Am J Cardiol
61:
1292-1299,
1988[Web of Science][Medline].
36.
Somers, VK,
Dyken ME,
Mark AL,
and
Abboud FM.
Sympathetic nerve activity during sleep in normal subjects.
N Engl J Med
328:
303-307,
1993
37.
Sundlof, G,
and
Wallin BG.
Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age.
J Physiol (Lond)
274:
621-637,
1978
38.
Task Force of the European Society of Cardiology.,
and
the North American Society of Pacing and Electrophysiology
heart rate variability standards of measurement, physiological interpretation, and clinical use.
Circulation
93:
1043-1065,
1996
39.
Thames, MD,
and
Abboud FM.
Reflex inhibition of renal sympathetic nerve activity during myocardial ischemia mediated by left ventricular receptors with vagal afferents in dogs.
J Clin Invest
63:
395-402,
1979.
40.
Wang, W,
Chen J,
and
Zucker IH.
Carotid sinus baroreceptor reflex in dogs with experimental heart failure.
Circ Res
68:
1294-1301,
1991
This article has been cited by other articles:
![]() |
M. Baumert, G. W. Lambert, T. Dawood, E. A. Lambert, M. D. Esler, M. McGrane, D. Barton, P. Sanders, and E. Nalivaiko Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H674 - H679. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Cassaglia, R. I. Griffiths, and A. M. Walker Cerebral sympathetic nerve activity has a major regulatory role in the cerebral circulation in REM sleep J Appl Physiol, April 1, 2009; 106(4): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Booth, L. Bennet, C. J. Barrett, S.-J. Guild, G. Wassink, A. J. Gunn, and S. C. Malpas Cardiac-related rhythms in sympathetic nerve activity in preterm fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R185 - R190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Jardine, C. J. Charles, C. M. Frampton, and A. M. Richards Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H433 - H439. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Jardine, C. J. Charles, R. K. Ashton, S. I. Bennett, M. Whitehead, C. M. Frampton, and M. G. Nicholls Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model J. Physiol., May 15, 2005; 565(1): 325 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. D. Watson, R. Mogulkoc, R. M. McAllen, and C. N. May Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1051 - R1056. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |